Kaihara M, Taniyama M, Tadatomo J, Tobe T, Tomita M, Ito K, Ban Y, Katagiri T
Third Department of Internal Medicine, School of Medicine, Showa University, Tokyo, Japan.
Endocr J. 1994 Jun;41(3):301-8. doi: 10.1507/endocrj.41.301.
We analyzed point mutations of N-ras protooncogene codon 61 in thyroid neoplasms by means of a mutation-specific PCR method. In this method, one of the paired primers has a base at the 3' terminal that is complementary to a mutated base of the DNA sequence to be analyzed. With this primer, only alleles which have the same mutation can be amplified. Among 24 thyroid tissues, we detected 2 point mutations out of 7 follicular carcinomas (29%). One tumor had a cytosine to adenine substitution mutation at the first base of codon 61, and the other had an adenine to guanine substitution mutation in the second base of the same codon. The same mutations were not detected in 7 follicular adenomas or 1 papillary carcinoma. These results were confirmed by both dot blot hybridization and direct sequencing method. Mutation of N-ras codon 61 may be significant in malignant transformation of follicular thyroid tumors. Because of its easy availability, the mutation-specific PCR method is a useful screening test for N-ras mutations.
我们采用一种突变特异性聚合酶链反应(PCR)方法,分析了甲状腺肿瘤中N-ras原癌基因第61密码子的点突变情况。在该方法中,一对引物中的一个在3'末端有一个碱基,该碱基与待分析DNA序列的突变碱基互补。使用该引物,只有具有相同突变的等位基因才能被扩增。在24个甲状腺组织中,我们在7个滤泡状癌(29%)中检测到2个点突变。一个肿瘤在第61密码子的第一个碱基处发生了胞嘧啶到腺嘌呤的替换突变,另一个在同一密码子的第二个碱基处发生了腺嘌呤到鸟嘌呤的替换突变。在7个滤泡状腺瘤或1个乳头状癌中未检测到相同的突变。这些结果通过斑点杂交和直接测序法得到了证实。N-ras第61密码子的突变可能在滤泡状甲状腺肿瘤的恶性转化中具有重要意义。由于其易于获得,突变特异性PCR方法是一种用于N-ras突变的有用筛查试验。